AG's IP is comprised of T Cells Receptor clonality analysis technology and T Central Memory Cell and Dendritic Cell preparation methodologies. The TCR clonality analysis technology is based on the use of multiple sets of unique primers to amplify 22 regions of the TCR, thereby detecting clonal expansions related to antigen stimulation of the immune system, which enables the assessment of tumor specific immunity with high accuracy and efficiency.
http://ift.tt/YNE2TX
http://ift.tt/YNE2TX
No comments:
Post a Comment